On the call from Digipath will be Joe Bianco (CEO), Todd Denkin (COO/President) and Cindy Orser (Chief Science Officer). Each member of the management team will discuss:
Tood Denkin, Founder and President:
Digipath Labs in Las Vegas
Digipath’s leadership position in the marketplace
On the ground business dynamics of the NV marketplace
The impact of recreational MJ passing in NV
Joe Bianco, CEO:
Capitalizing on Digipath’s NV success
Plans for expansion and why it’s such a good move NOW
Strategic licensing and joint venture opportunities
M&A opportunities for Digipath
Cindy Orser, PhD, Chief Science Officer:
How Nevada has set the standard for other MMJ states to follow
Why standardization in cannabis testing is needed
Integration of MMJ with retail MJ
Strain genotyping, chemometrics and the future
There will be a Q&A session towards the end of the conference call. Interested parties that want to submit questions must do so prior to the call by sending an email to hphillips@viridianca.com.
The dial-in numbers for the corporate update call are as follows:
Program Title: Digipath, Inc. Corporate Update
Call in US: 1-310-372-7549
Call in Canada: 1-647-478-7145
Conference Code: 348812
About Digipath, Inc.
Digipath, Inc. is an independent cannabis testing and media firm that supports the cannabis industry’s best practices for reliable testing and delivers cannabis news coverage and education about the cannabis industry. Digipath’s two business units are Digipath Labs and TNM News Corp. Digipath Labs™ is working to set the industry standard for testing all forms of cannabis-based products using FDA-compliant laboratory equipment and proprietary standard operating procedures (SOP) to ensure product safety and efficacy. TNM News Corp. has pioneered a cannabis-focused news network, The National Marijuana News, which delivers news, interviews, and education on all things cannabis. For more information please visit www.Digipath.com/
Forward-Looking Statements
This press release contains “forward-looking statements” that include information relating to future events, and future financial and operating performance. Forward looking statements should not be read as a guarantee of future performance or results, and will not necessarily be accurate indications of the times at, or by, which that performance or those results will be achieved. Forward-looking statements are based on information available at the time they are made and/or management’s good faith belief as of that time with respect to future events, and are subject to risks and uncertainties that could cause actual performance or results to differ materially from those expressed in, or suggested by, the forward-looking statements. Important factors that could cause these differences include, but are not limited to: the Company’s need for additional funding, governmental regulation of the cannabis industry, the demand for the Company’s products, the introduction of new products, the Company’s ability to maintain customer and strategic business relationships, the impact of competitive products and pricing, growth in targeted markets, the adequacy of the Company’s liquidity and financial strength to support its growth, and other information that may be detailed from time-to-time in the Company’s filings with the United States Securities and Exchange Commission. For a more detailed description of the risk factors and uncertainties affecting Digipath, please refer to the Company’s recent Securities and Exchange Commission filings, which are available at www.sec.gov. The Company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise.
